Genscript Biotech Co. (OTCMKTS:GNNSF) Sees Large Growth in Short Interest

Genscript Biotech Co. (OTCMKTS:GNNSF) saw a significant growth in short interest in the month of July. As of July 15th, there was short interest totalling 5,588,000 shares, a growth of 6.4% from the June 30th total of 5,253,800 shares. Based on an average daily volume of 120,200 shares, the days-to-cover ratio is currently 46.5 days.

Genscript Biotech Price Performance

Shares of GNNSF remained flat at C$1.60 during trading hours on Wednesday. 50 shares of the stock traded hands, compared to its average volume of 97,967. The stock has a 50 day moving average price of C$1.24 and a two-hundred day moving average price of C$1.63. Genscript Biotech has a 52 week low of C$1.05 and a 52 week high of C$3.20.

About Genscript Biotech

Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, the People's Republic of China, Japan, the other Asia Pacific regions, and internationally. The company operates through four segments: Life Science Services and Products; Biologics Development Services; Industrial Synthetic Biology Products; and Cell Therapy.